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1. Introduction
  Tuberculosis (TB) is a highly infectious disease currently 
infecting around 1/3 of the world’s population[1]. As per the 
WHO estimate, there are 9 million cases of active TB with 
1.3 million reported deaths every year at present[2]. Asian 
and African countries shares major TB burden with 55% and 
30% of the total reported cases respectively[3]. Currently used 
anti-mycobacterial drugs, namely, rifampicin, isoniazid, 
streptomycin and ethambutol, were introduced in TB control 
programmes almost three decades ago. Indiscriminate use 
of these drugs has led to the development of multi-drug-
resistant (MDR) and extensively drug-resistant (XDR) strains 
of Mycobacterium tuberculosis (M. tuberculosis), making 
the treatment difficult and increasing TB burden[4-7]. 
The emergence of MDR and XDR strains and increase in 
TB burden necessitated the urgent need for new anti-
mycobacterial drugs. 
  Medicinal plants have been used worldwide by traditional 
medicinal practitioner for the treatment of various 
diseases. Approximately 60% of world’s population still 
relies on medicinal plants for their primary healthcare. 
The advantage of plant based drug discovery is that the 
phytochemicals provide novel drug leads with novel 
mechanism of action. Anti-mycobacterial phytochemicals 
may be helpful in identification of new molecular targets in 
MDR and XDR strains of mycobacterium opening new vistas 
for anti-tubercular drug discovery. A number of medicinal 
plants have been screened for anti-mycobacterial activity 
in past few years[8-12]. Some plants have shown promising 
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results[13], but very few active molecules have been purified. 
In the Indian subcontinent which is rich in traditional 
knowledge of “Ayurveda”, studies have been carried out on 
anti-mycobacterial activity of medicinal plants[14-15]. Present 
study was carried out to evaluate invitro anti-mycobacterial 
activity of Cassia sophera (C. sophera), Urtica dioica (U. 
dioica), Momordica dioica (M. dioica), Tribulus terrestris (T. 
terrestris) and Coccinia indica (C. indica) plants. C. sophera 
Linn. (Caesalpiniaceae) is used for treatment of psoriasis, 
cough, arthritis, diabetes and convulsions[16]. Its extracts are 
used against ringworm[17] and also possess hepatoprotective 
activity[18]. M. dioica Roxb. (Cucurbitaceae) possess anti-
allergic[19], analgesic and anti-inflammatory[20] and anti-
diabetic activity[21]. T. terrestris Linn. (Zygophyllaceae) is 
used as tonic, aphrodisiac, analgesic, astringent, stomachic, 
antihypertensive, diuretic and lithontriptic and also for 
the treatment of urinary tract infections[22]. U. dioica Linn. 
(Urticaceae) possess antioxidant, antimicrobial, antiulcer 
and analgesic activities[23].  
  Screening of medicinal plant for anti-mycobacterial 
activity involves large number of solvent extracts. Screening 
large number of extracts on slow growing, pathogenic 
M. tuberculosis strain is a major problem. In this study, 
various solvent extracts of five selected medicinal plants 
were screened against fast growing, non-pathogenic 
Mycobacterium semegmatis (M. semegmatis). The extracts 
possessing promising activity were tested against standard, 
MDR and clinical isolates of M. tuberculosis. The most active 
extracts were further fractionated and tested against M. 
tuberculosis.
2. Materials and methods
2.1. Strains, culture media and chemicals
  Preliminary screening of various solvent extracts was 
carried out on non-pathogenic fast growing mycobacterial 
strain, M. semegmatis (MC2-155). The active extracts were 
tested on M. tuberculosis standard strain H37Rv (ATCC-
35838), MDR strains, and clinical isolates CL-1 (+3) and 
CL-2 (+2). Anti-mycobacterial activity of extracts against 
these strains was observed in Department of Microbiology, 
Maharani Laxmi Bai Medical College, Jhansi, India. 
Mycobacterial culture media [Middle brook 7H11 agar, 
Middle brook 7H9 broth, and Lowenstein-Jensen (L-J) 
medium], media supplements and standard antibiotics were 
obtained from Himedia (Mumbai, India). Other chemicals 
used in the study were of high purity and purchased 
commercially. 
2.2. Collection of plant materials and extraction
  Fresh aerial parts of T. terrerstris and fruits of C. indica and 
M. dioica were collected from local hills of Bundelkhand 
University during May-August, 2010. Dried seeds of C. 
sophera were obtained from drug manufacturing unit of 
Sree Baidyanath Ayurved Bhavan Ltd (Jhansi, India). The 
plant materials were identified with the help of experts 
in Department of Botany, Bundelkhand University. The 
voucher specimens with no. BU/BMS/VS/2010/01 (C. indica), 
BU/BMS/VS/2010/02 (T. terristeris), BU/BMS/VS/2010/03 (M. 
dioca) and BU/BMS/VS/2010/04 (C. sophera) were preserved 
in Department of Biomedical Sciences, Bundelkhand 
University. Leaves of U. dioica were collected from Anantnag 
district of the Kashmir Valley, India in October, 2009 and 
authenticated by the Centre of Biodiversity & Taxonomy, 
Department of Botany, University of Kashmir and a voucher 
specimen (28100 KASH) was deposited. The plant materials 
were dried in shade, ground to obtain coarse powder and 
stored at -40 °C in airtight containers until use.  
  Plant materials (100 g) were sequentially extracted for 12 
h with hexane, chloroform, ethyl acetate and methanol in 
soxhlet apparatus. The residues after methanol extraction 
was soaked in distilled water at 60 °C for 12 h with constant 
stirring. The solvent extracts were filtered twice with 
Whatman’s filter paper and centrifuged at 3 000 r/min for 15 
min to remove any residual material. The organic solvents 
extracts were dried in a rotary evaporator (Heidolph, 
Germany) under vacuum and water extracts were lyophilized 
in freeze dryer (Martin Christ, Germany). The extracts were 
stored in glass vials at -40 °C until use.
2.3. Anti-mycobacterial activity against M. semegmatis
2.3.1. Preliminary screening by disk diffusion method
  Stock solutions (200 mg/mL) of hexane, chloroform, ethyl 
acetate and methanol extracts were prepared in dimethyl 
sulphoxide (DMSO), whereas water extracts were dissolved in 
water. Petri plates with Middle brook 7H11 agar were seeded 
with 100 μL of M. semegmatis culture at a concentration 
of 1.5×106 cells/mL (OD adjusted to the 0.5 McFarland’s 
turbidity standards). Sterile filter paper discs (6 mm in 
diameter) impregnated with 2 mg/disc of plant extracts were 
placed on the Petri plates. Rifampicin (20 μg/disc) was used 
as positive and a disc soaked in 10 μL of DMSO served as 
solvent control. The inoculated plates were incubated for 72 
h and the results were recorded by measuring diameter of 
growth inhibition zone[24]. All experiments were carried out 
in triplicate. 
2.3.2. Minimum inhibitory concentration (MIC) by broth 
dilution method
  MIC was determined for plant extracts exhibiting growth 
inhibition zone of more than 10 mm in disc diffusion assay. 
The extracts were dissolved in DMSO and stock solution (2 
mg/mL) was prepared in Middle brook 7H9 broth. The extracts 
were successively diluted to half (10 times) with 7H9 broth to 
obtain 10 concentrations, ranging from 2 000 to 3.9 μg/mL. 
The tubes were inoculated with 100 μl of M. semegmatis 
(1x106 cells/mL, OD adjusted to the 0.5 McFarland’s turbidity 
standards). Rifampicin (64 μg/mL) was used as a standard 
drug for comparison and DSMO (10 μL/mL) served as 
solvent control. The tubes were incubated aerobically at 
37 °C for 72 h followed by addition of 50 μL of 0.2 mg/mL 
2-(4-iodophenyl)-3-(4-nitrophenyl)-5-phenyltetrazolium 
chloride (INT) solution. The tubes were observed for color 
change and the concentration at which a decrease in red 
color (reduction of INT to formazan by bacteria) was apparent 
compared to the next higher concentration was taken as MIC 
value[25]. All experiments were carried out in triplicate.
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2.4. Phytochemical screening
  The bioactive extracts were tested for alkaloids, 
saponins, flavonoids, tannins, terpenoids, anthraquinones, 
phlobatannins and cardiacglycosides[26-28]. 
2.5. M. semegmatis activity guided purification of methanol 
extract of C. sophera (MECS) and hexane extract of U. dioica 
(HEUD)
2.5.1. Thin layer chromatography (TLC) bio-autoassay
  MECS and HEUD possessing good activity in disc diffusion 
assay with promising MIC were subjected to bio-autoassay 
on silica TLC plates (Merck, Kiesel 60 F254, 0.2 mm 
thickness). MECS and HEUD were resolved on TLC plates 
with standardized mobile phase. The TLC plates were dried 
in air and dipped in Middle brook 7H11 agar Petri plates 
and seeded with M. semegmatis as per procedure followed 
for disc diffusion assay. After 72 h of incubation, plates were 
sprayed with INT to record zones of growth inhibition to 
indentify active band on TLC.
2.5.2. Column chromatography 
  MECS and HEUD were fractionated on silica gel (Merck, 
60-120 mesh) column chromatography. For MECS, the 
column was eluted with chloroform/methanol gradient 
(10:0-0:10). The fractions were analyzed by TLC and pooled 
to 10 fractions (F1, F2, F3…, F10). For HEUD, the column 
was eluted with hexane/ethyl acetate gradient (10:0-0:10). 
The fractions were analyzed by TLC and pooled to give 20 
fractions (F1, F2, F3…, F20). All the fractions were tested 
for anti-mycobacterial activity on M. semegmatis by disc 
diffusion assay and compared with active bands of TLC bio-
auto-assay for identification of anti-mycobacterial active 
subfractions. 
2.6. Anti-mycobacterial activity against M. tuberculosis
    
  MECS, HEUD and their active subfractions were tested for 
anti-mycobacterial activity on standard, MDR and clinical 
isolates of M. tuberculosis by the proportion and absolute 
concentration methods.
2.6.1. Preparation of mycobacterial suspension
  Approximately 4 mg of M. tuberculosis culture [visualized 
as 2/3 loopful, 3 mm internal diameter, 0.558 mm (24 SWG) 
thick wire loop] was added in 0.3 mL of sterile distilled water 
in a Bijou bottle and vortexed for 30 s to prepare a uniform 
suspension. Sterile distilled water (3.7 mL) was added to 
obtain 1 mg/mL suspension (S1). The suspension was kept 
on the bench for 15-20 min to allow the coarser particles to 
settle down.
2.6.2. Absolute concentration method
  Standardized inoculums of M. tuberculosis (4 μL of 1 mg/mL 
bacterial suspension) was cultured on drug-free L-J media 
and media containing rifampicin (32, 64 and 128 μg/mL), 
isoniazid (0.2, 1.0, 5.0 μg/mL), ethambutol (2, 4 and 6 μg/mL), 
streptomycin (8, 16 and 32 μg/mL), MECS, F2 of MECS, HEUD 
and F18 of HEUD (62.5, 125.0, 250.0, 500.0, 1 000.0 μg/mL). 
L-J media slopes were incubated aerobically at 37 °C for 4 
weeks. The lowest concentration of the plant extracts which 
inhibited the growth of M. tuberculosis (less than 20 colonies) 
was recorded as MIC[29]. 
2.6.3. Proportion method
  Ten fold serial dilution suspensions S2, S3 and S4 were 
prepared from S1 in distilled water and inoculated [1 loopful, 
3 mm external diameter, 0.558 mm (24 SWG) thin wire loop] 
on L-J slopes. The plant extracts were incorporated in the 
L-J media at concentration of 2% (v/v) and 4% (v/v) (2 mg and 
4 mg of plant extracts were dissolved in minimum amount of 
DMSO and added to 100 mL of culture medium). Rifampicin 
(40 μg/mL), isoniazid (0.2 μg/mL), ethambutol (2 μg/mL) and 
streptomycin (8 μg/mL) were used as positive controls in the 
assay. The cultures were incubated for 4 weeks and visible 
colonies were counted[29].
3. Results
3.1. Anti-mycobacterial activity against M. semegmatis
  The plant extracts showed low to good anti-mycobacterial 
activity in the disc diffusion assay. The HEUD and MECS 
were the most active extracts producing zone of inhibition 
with a diameter of 20 mm. The aqueous extracts of all plants 
except that of C. sophera showed low activity (Table 1). 
  The MIC of the most active extract of each plant (HEUD, 
MECS, and methanol extracts of M. dioica, C. indica and 
T. terrestris) was determined by broth dilution assay. The 
HEUD and MECS were the most active extracts showing MIC 
value of 250 and 125 μg/mL, respectively. The methanol 
extracts of M. dioica, C. indica and T. terrestris showed MIC 
values of 500, 1 000 and 500 μg/mL, respectively. The most 
active extracts MECS and HEUD were subjected to TLC bio-
autoassay and fractionated by column chromatography to 
isolate active molecule(s).    
3.2. Phytochemical analysis
  The most active extract of each plant was tested for various 
Table 1
Inhibition zone diameters (mm) by various plant extracts against M. semegmatis in disc diffusion assay.
Plant
Solvent extract
DMSO Rifampicin
Hexane Chloroform Ethyl acetate Methanol Aqueous
C. sophera   9   7   9 20 12 7 29
M. dioica   6   9 12 13   7 6 29
C. indica 10   8   9 12   9 7 28
T. terrestris   9   9 12 13   8 6 28
U. dioica 20 15 10 10   7 6 28
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phytochemicals. Alkaloids, saponins, terpenoids, tannins 
and flavonoids were predominantly present in the active 
extracts (Table 2). Alkaloids and saponins were present in 
all active extracts except the HEUD. Phlobatannins were 
absent in all the extracts. Cardiac glycosides were present 
only in the MECS. The MECS contained alkaloids, saponins, 
flavonoids, tannins, anthraquinons and cardiac glycosides. 
The HEUD contained tannins, terpenoids and anthraquinons.
3.3. Isolation of bioactive compounds by TLC bio-autoassay 
and column chromatography
  Active zones of the HEUD and MECS on TLC were identified 
bio-autoassay (Results not shown). TLC bio-autoassay 
helped to identify the active fractions of HEUD and MECS 
obtained from column chromatography.
  Ten pooled fractions (F1-F10) obtained on silica column 
and eluted with chloroform/methanol gradient were 
subjected to anti-mycobacterial disc diffusion assay on 
M. semegmatis. F1-F3 were active. The F2 obtained at 98:2 
chloroform:methanol was the most active and it produced 27 
mm zone of inhibition in disc diffusion assay. TLC of F2 was 
compared with TLC bio-autoassay of MECS for identification 
of active bands.
  Twenty pooled fractions (F1-F20) obtained on silica 
column and eluted with hexane/ethyl acetate gradient were 
subjected to anti-mycobacterial disc diffusion assay on 
M. semegmatis. F15-F18 were active. F18 obtained at 77:23 
hexane:ethyl acetate was the most active and produced 24 
mm zone of inhibition in disc diffusion assay. TLC of F18 was 
compared with TLC bio-autoassay of HEUD for identification 
of active bands. 
3.4. Anti-mycobacterial activity against M. tuberculosis
  
3.4.1. MIC 
  MIC, mean CFU value, inhibition rate by HEUD, MECS and 
their semipurified fractions were evaluated against H37Rv, 
CL-1 and CL-2 (Table 3).  
3.4.2. Mean CFU and inhibition rate
  MECS, HEUD and their semipurified fractions showed 
significant M. tuberculosis growth inhibition on L-J media 
slopes. Semipurified fraction F2 from MECS produced 
86% inhibition, whereas F18 from HEUD produced 81% 
inhibition at 4% (v/v) concentration in CL-1 culture. F2 and 
F18 produced 60% inhibition against MDR and 68% and 79% 
inhibition against standard strain, respectively. The result 
showed that M. tuberculosis growth inhibition by HEUD, 
MECS and their purified subfractions was dose dependant 
with 4% (v/v) concentration producing more effect as 
compared to 2% concentration (Table 3). 
Table 3
Anti-mycobacterial assay using plant extracts against M. tuberculosis.
Extract/fraction Strain MICa (μg/mL)
Mean CFU on media Inhibition rate (%)
Control
2% (v/v) plant 
extract
4% (v/v) plant 
extract
2% (v/v) plant 
extract
4% (v/v) plant 
extract
Methanol extract of C. 
sophera (MECS)
H37RV 500 47 27 13 42 72
MDR 500 27 14 10 49 62
CL-1 250 71 25 15 65 79
CL-2 125 66 24 12 63 81
Hexane extract of U. 
dioica (HEUD)
H37RV 250 47 22 12 53 74
MDR 500 28 16 15 43 46
CL-1 250 72 21 17 71 76
CL-2 250 65 24 20 63 69
F2 fraction of MECS H37RV 250 47 26 15 45 68
MDR 250 25 12 10 52 60
CL-1 125 72 21 10 70 86
CL-2 125 65 27 11 58 83
F18 fraction of HEUD H37RV 250 47 19 10 60 79
MDR 250 30 14 12 54 60
CL-1 125 72 19 14 74 81
CL-2 125 65 19 10 71 78
aMIC was determined by absolute concentration method.
Table 2
Phytochemical analysis.
Plant Extract Alkaloids Saponins Flavonoids Tannins Terpenoids Anthraquinones Phlobatannins Cardiac glycosides
C. sophera Methanol + + + + - + - +
M. dioica Ethylacetate + + + +  - - -  -
C. indica Methanol + + + + + +  -  -
T. terrestris Methanol + +  - + -  -  - - 
U. dioica Hexane - -  - + + + - -
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 4. Discussion
  WHO declared TB as global health emergency because 
of the increase in HIV co-infection and the appearance of 
MDR and XDR strains[30]. No new anti-mycobacterial drug 
has been introduced in past 30 years, hence, there is an 
urgent need to develop novel, safe, effective and affordable 
drug for treating resistant forms of TB. There has been a 
renewed interest in phytochemicals as source of novel 
therapeutics in the past decade, hence, plants have been 
investigated for various pharmacological effects including 
anti-mycobacterial activity. A number of plants have 
been reported to possess anti-mycobacterial activity[11,31]. 
Phytochemicals may become the base for new drug 
development by providing a pharmacophore which could be 
used for the development of new drug with novel mechanism 
of action. Recently anti-mycobacterial activity of Adhatoda 
vasica, Acalypha indica, Aloe vera, Allium cepa and Allium 
sativum have been reported against MDR strains of M. 
tuberculosis[14].
  In current study, in vitro anti-mycobacterial activity of 
C. sophera, U. dioica, M. dioica, T. terrestris and C. indica 
have been evaluated. There are reports of screening of large 
number of plant extracts against fast growing, nonpathogenic 
M. semegmatis and the active extracts have also exhibited 
activity against M. tuberculosis[26]. Out of five plants selected 
in this study, C. sophera and U. dioica were identified 
as potentially active in disc diffusion assay against M. 
semegmatis. MECS and HEUD produced 20 mm inhibition 
zone, whereas rifampicin produced 28 mm inhibition 
zone. The MIC of these extracts was 125 and 250 μg/mL 
respectively, which may be considered very promising for 
crude extracts having large number of compounds. No anti-
mycobacterial activity has been reported earlier from the 
genus Cassia and this is perhaps the first report of anti-
mycobacterial activity from C. sophera, hence, MECS was 
processed further for purification of active molecule(s). 
The semipurified fraction F2 of MECS obtained at 98:2 
chloroform/methanol was the most active and it produced 
27 mm zone of inhibition in disc diffusion assay on M. 
semegmatis. The MIC of was 125 μg/mL against CL-1 and 
CL-2 and 250 μg/mL against standard and MDR strain of M. 
tuberculosis. The findings indicated that partial purification 
of MECS improved the activity against the tested strains, 
probably due to increase in concentration of the active 
molecule(s). The phytopharmaology of C. sophera is not 
explored extensively having very few published reports[32]. 
Since this is the first report of anti-mycobacterial activity 
of MECS, its phytochemical analysis was carried out. 
MECS showed presence of alkaloids, saponins, flavonoids, 
tannins, anthraquinons and cardiac glycosides. Alkaloids 
from a number of plants have been reported to possess 
anti-mycobacterial activity[11]. Anti-mycobacterial 
activity alkaloid vasicine from A. vasica have already been 
reported[33]. Other important anti-mycobacterial alkaloids 
includes berberine from Hydrastis canadensis[34] and 
chabamide from Piper chaba[35]. Flavonoids are another 
important class of phytochemicals possessing anti-
mycobacterial activity. Ferulenol form Ferula communis[36], 
licochalcone A from Glycyrrhiza glabra[37] and phaseollidin 
from Erythrina gibbosa[38] are few of the potential anti-
mycobacterial flavonoids isolated form plants. Anti-
mycobacterial activity of MCES may be due to presence to 
alkaloids or flavonoids. Antimicrobial activity of hexane 
extract of U. dioica has been reported earlier by our group. 
The antibacterial subfraction from hexane extract of U. 
dioica showed presence of neophytadiene (26.97%), butyl 
tetradecyl ester (9.53%), dibutyl phthalate (7.45%), bis 
(2-ethyl hexyl) maleate (8.80%) and 1,2- benzenedicarboxylic 
acid (9.89%) as the principal terpenes[25]. In this study, 
HEUD exhibited promising anti-mycobacterial activity 
against M. semegmatis and M. tuberculosis as compared to 
other solvent extracts. The phytochemical analysis of HEUD 
showed presence of tannins, terpenoids and anthraquinons. 
Plant terpenoids have already been reported to exhibit 
antimicrobial activity[39]. The finding suggested that 
terpenoids present in HEUD may be responsible for anti-
mycobacterial activity. Semipurified fractions F2 of MECS 
and F18 from HEUD produced 86% and 81% inhibition at 4% 
(v/v) concentration against clinical isolate of M. tuberculosis. 
The effect of semipurified fractions was better as compared 
to their crude extracts, suggesting that active molecule(s) 
may have concentrated during the process of purification. 
Moreover, 4% (v/v) extract was more active as compared to 
2% extract, indicating that the effect was dose dependant.
  In conclusion, C. sophera and U. dioica plant extracts 
exhibited promising anti-mycobacterial activity against 
MDR strain of M. tuberculosis. This is the first report of 
anti-mycobacterial activity of C. sophera. This study 
showed possibility of purifying novel anti-mycobacterial 
compound(s) from C. sophera and U. dioica. 
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